e-Newsletter December 2025
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Search results
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Researchers from the University Hospital Tübingen in Germany recently announced that there were no signs of visual gains in an early-phase clinical trial of a PDE6A gene therapy for Retinitis Pigmentosa (RP).
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Our young adults got to grips with white water rafting recently, building confidence and resilience while having fun.
Do you know your facts from your fiction? Host a quiz for Retina UK and raise vital funds for our ground-breaking work.
The aim of these pages is to increase the level of awareness and understanding of genetic testing and genetic counselling among people living with inherited retinal dystrophies, empowering them to make fully informed decisions about their lives, healthcare and family planning.
The eye is a very complex organ. It has a lens at the front which focuses light on to a light sensitive tissue that lines the inside of the back of the eye – this tissue is called the retina.
Many inherited sight loss conditions occur when cells in the retina, which is the light-sensitive region at the back of the eye, deteriorate in an unpredictable way. These conditions are often referred to as inherited retinal dystrophies.
Making yourself aware of the what you are entitled to, and understanding the diagnosis pathway for inherited sight loss, will put you in a stronger position to seek better support.
Tomasz Tomkiewicz is undertaking a PhD studentship funded by Retina UK and The Macular Society.